Clinical Trial Update: Study to Test an Approved Product in the Early Treatment of Migraine (0462-065) [Phase 3]

View source ↗

Summary

A Phase 3 trial (0462-065) tested an approved product for early treatment of migraine and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Organon and Co | Conditions: Migraine | Phase 3 | Status: COMPLETED